Skip to main content
HeartCited

Calcium para High Blood Pressure (Hypertension)

C Evidencia Evidencia limitada de estudios pequeños, pero existen algunas señales positivas.

Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dcalcium\u0026condition\u003Dhigh\u002Dblood\u002Dpressure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Conclusión

Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.

Key Study Findings

Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None vs: Standard care or placebo Outcome: Global cognition in stroke survivors Efecto: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins) 0.009 (protein); 0.02 (B-vit)

Población: Adult stroke survivors (20 trials + 14 observational)

Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily vs: Placebo Outcome: Preeclampsia risk reduction Efecto: ~50% risk reduction None

Población: Pregnant women with low calcium intake

Review
Novel pharmacologic approaches in resistant hypertension.
Dose: Spironolactone, sacubitril/valsartan, SGLT2i vs: None Outcome: Blood pressure control in resistant HTN Efecto: None None

Población: Patients with resistant hypertension

Review
Vegan Diet Health Benefits in Metabolic Syndrome.
Dose: None vs: None Outcome: None Efecto: None None

Población: Adults with metabolic syndrome

cross-sectional observational study n=260
Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers.
Dose: None vs: Placebo Efecto: None None
Observational Study n=40
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Dose: anti-digoxin antibodies (Fab) vs: pre-treatment Outcome: serum digoxin and clinical outcomes Efecto: Fab bound digoxin; no improved clinical outcomes None

Población: Chronic digoxin toxicity patients

Key Statistics

13

Estudios

1500

Participantes

Mixed

C

Calificación

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

note:
Prefer dietary sources; limit supplements to 500 mg/dose
general:
1,000-1,200 mg/day from diet plus supplements

Límite superior: 2,000-2,500 mg/day (total from diet and supplements)

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Mixed --
500 mg daily -- Positive --
Spironolactone, sacubitril/valsartan, SGLT2i -- Positive --
None -- Mixed --
None -- Neutral 260
anti-digoxin antibodies (Fab) -- Neutral 40
None -- Mixed --
None -- Neutral 2991

Mejor momento para tomar: Divide doses (500 mg max per dose); carbonate with meals; citrate any time

Safety & Side Effects

Efectos secundarios reportados

  • Constipation (especially carbonate form)
  • Potential increased MI risk with high-dose supplements (controversial)
  • Kidney stones at excessive doses
  • Gas, bloating

Interacciones conocidas

  • Thyroid medications (separate by 4 hours)
  • Bisphosphonates (separate by 30-60 minutes)
  • Iron supplements (reduced absorption — separate by 2 hours)
  • Certain antibiotics (reduced absorption)
  • Vitamin K2 (may help direct supplemental calcium to bones, not arteries)

Ingesta máxima tolerable: 2,000-2,500 mg/day (total from diet and supplements)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Calcium help with High Blood Pressure (Hypertension)?
Based on 13 studies with 1,500 participants, there is limited but promising evidence that Calcium may support High Blood Pressure (Hypertension) management. Our evidence grade is C (Some Evidence).
How much Calcium should I take for High Blood Pressure (Hypertension)?
Studies have used various dosages. A commonly studied range is Prefer dietary sources; limit supplements to 500 mg/dose. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Calcium?
Reported side effects may include Constipation (especially carbonate form), Potential increased MI risk with high-dose supplements (controversial), Kidney stones at excessive doses, Gas, bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Calcium and High Blood Pressure (Hypertension)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 13 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.

References

  1. [1] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
  2. [2] Sasan Amanat et al.. Adv Nutr. 2025. Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis. doi:10.1016/j.advnut.2025.100440 PubMed
  3. [3] Jerzy Głuszek. Wiad Lek. 2024. Novel pharmacologic approaches in resistant hypertension. doi:10.36740/WLek/194090 PubMed
  4. [4] Giulia Marrone et al.. Nutrients. 2021. Vegan Diet Health Benefits in Metabolic Syndrome. doi:10.3390/nu13030817 PubMed
  5. [5] Niloufar Zadeh Saraji et al.. J Renal Inj Prev. 2017. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. doi:10.15171/jrip.2017.27 PubMed
  6. [6] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
  7. [7] Alfonso Eirin et al.. Trends Cardiovasc Med. 2016. Emerging concepts for patients with treatment-resistant hypertension. doi:10.1016/j.tcm.2016.05.004 PubMed
  8. [8] Behzad Einollahi et al.. Nephrourol Mon. 2014. Restless leg syndrome: a neglected diagnosis. doi:10.5812/numonthly.22009 PubMed
  9. [9] Jian-hong Li et al.. Zhongguo Zhong Yao Za Zhi. 2014. [Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database]. PubMed
  10. [10] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
  11. [11] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.